Stock data

久裕 (4173)

久裕 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$178.66M, up 42.1% from a year earlier. EPS over the last four quarters totals NT$0.80.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 久裕 in Insightr